SNCA and Parkinson disease: In AD, apolipoprotein E4 (APOE4) status alters lipid metabolism, amyloid clearance, and synaptic repair; in PD, mutations in LRRK2, PARKIN, PINK1 and SNCA genes converge on mitochondrial dysfunction, impaired autophagy, and αSyn pathology [71,72,73].